Le Lézard
Classified in: Health
Subjects: SVY, LGB

Sexual Orientation Identified as a Risk Factor in Opioid Misuse


NEW YORK, Nov. 19, 2018 /PRNewswire/ -- Men and women who identify as lesbian, gay, or bisexual are more likely to misuse opioids when compared with those who identify as heterosexual, a new study shows.

(PRNewsfoto/NYU School of Medicine)

Led by researchers at NYU School of Medicine and published online Nov. 19 in the American Journal of Preventive Medicine, the study estimates that 5 percent of adults who identify as heterosexual in the U.S. have misused opioids in the past year, while the number climbs to 9 percent for individuals who identify as gay or lesbian, and 12 percent for those who identify as bisexual. And just within the past month, 1 percent of those who identify as heterosexual have used opioids, while 4 percent of those who identify as bisexual have.

The study relies on data from among 42,802 people involved in the 2015 National Survey on Drug Use and Health (NSDUH). Study participants were surveyed about their sexual orientation and any misuse of opioids in the past year, as well as past-month and past-year prescription opioid use. Misuse was categorized as using the drug without a prescription, using in larger amounts or for longer than directed, or using against a doctor's recommendation.

According to researchers, previous studies have found that those who identify as gay or bisexual are more likely to use drugs and experience addiction-related illnesses, such as alcoholism and use of other drugs. Researchers say the new study is the first of its kind to examine differences in sexual orientation using a nationally representative sample of adults in the U.S.

Among the study's key findings were that women who identified as bisexual were twice as likely to misuse opioids when compared with individuals with other sexual orientations.

"Our study highlights that adults of sexual minority status ? particularly women identifying as bisexual ? are at increased risk for opioid misuse," says senior study author Joseph J. Palamar, PhD, MPH, an associate professor in the Department of Population Health at NYU School of Medicine and a researcher in the Center for Drug Use and HIV/HCV Research at NYU College of Global Public Health. "With the opioid crisis escalating nationwide, it is important to focus on preventing misuse among groups at highest risk."

The researchers believe the underlying cause of opioid misuse among bisexual women could be their need for a coping mechanism from the stress and stigma that arises from being not only a minority within a largely heterosexual culture, but also within the lesbian and gay community.

To address the growing problem of opioid misuse in these groups, the researchers advocate for the development of more educational programming to help prevent drug use and misuse.

"Primary care providers, educators, and even parents should consider sexual orientation when assessing those at risk of opioid misuse," says Dustin T. Duncan, ScD, an associate professor in the Department of Population Health at NYU School of Medicine, a researcher in the Center for Drug Use and HIV/HCV Research, and lead author on the study. "Not only do we need to consider sexual orientation as a risk factor, but we also need to monitor these groups more closely once they've been identified."

In addition to authors Duncan and Palamar, Sophia Zweig, BS, and H. Rhodes Hambrick, BS, from NYU Langone Health, served as research assistants on this study.

Funding support for the study was provided by National Institutes of Health grant K01 DA038800.

Media Inquiries:
Jamie Liptack
212-404-4279
[email protected]

SOURCE NYU Langone Health


These press releases may also interest you

at 02:48
Today, RaySearch Laboratories AB (publ)  publishes its Annual Report for the financial year 2023. The report is held available on RaySearch's website, under the section Investors.  This information is information that RaySearch Larboratiories AB...

at 02:43
Shareholders of Zinzino AB (publ) are hereby invited to the annual general meeting on Monday, May 27, 2024, at 1:30 PM at the company's premises at Hulda Mellgrens gata 5 in Gothenburg. Registration begins at 1:15 PM. The company aims to webcast the...

at 02:41
Implantica AG (publ), a med-tech company at the forefront of bringing advanced technology into the body, is publishing its annual report for the fiscal year 2023. The annual report is now available on the company's website. "Implantica had a very...

at 02:08
Revenue amounted to ?498.8m (?419.3m), an increase of 18.9% with an organic growth of 14.2%.Operating profit (EBIT) was ?19.0m (?10.7m), an increase of 78.0%, representing an operating margin of 3.8% (2.6%).Net profit amounted to ?6.5m (?2.1m), which...

at 02:00
Amwins Global Risks is delighted to announce Classic Cars and Cotswolds, an auction to raise money for the Matthew Wilson Multiple Myeloma Fund at Blood Cancer UK. The online auction opens today and features Ferraris, Aston Martins, a Rolls Royce, a...

at 01:35
Regulatory News: Sensorion (FR0012596468 ? ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, today announces...



News published on and distributed by: